Bay Street News

Valeant Pharmaceuticals Receives Lender Consent For Credit Facility Amendment

Intends to File 10-K on or before April 29, 2016, as Previously Disclosed 

LAVAL, Quebec, April 7, 2016 /CNW/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that it has obtained the requisite lender approval for the amendment and waiver to…